Lars Påhlman

Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer

Ellen Kapiteijn, Corrie A.M. Marijnen, Irıs D. Nagtegaal et al. · New England Journal of Medicine · 2001 · 4.2K citations · Full text

Medicine, Oncology, Surgery +16

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial

W. van Gijn, Corrie A.M. Marijnen, Irıs D. Nagtegaal et al. · The Lancet Oncology · 2011 · 1.9K citations

Medicine, Oncology, Surgery +17

Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial

Renu R. Bahadoer, Esmée A. Dijkstra, Boudewijn van Etten et al. · The Lancet Oncology · 2020 · 1.6K citations · Full text

Medicine, Oncology, Surgery +17

The TME Trial After a Median Follow-up of 6 Years

Koen Peeters, Corrie A.M. Marijnen, Irıs D. Nagtegaal et al. · Annals of Surgery · 2007 · 1.2K citations

Medicine, Oncology, Surgery +17

Swedish Rectal Cancer Trial: Long Lasting Benefits From Radiotherapy on Survival and Local Recurrence Rate

Joakim Folkesson, Helgi Birgisson, Lars Påhlman et al. · Journal of Clinical Oncology · 2005 · 863 citations · Full text

Medicine, Oncology, Surgery +14